Inhibition of DNMT suppresses the stemness of colorectal cancer cells through down-regulating Wnt signaling pathway. 2018

Shanxin Li, and Zhipeng Han, and Naping Zhao, and Bing Zhu, and Qianwen Zhang, and Xue Yang, and Dandan Sheng, and Jing Hou, and Shiwei Guo, and Lixin Wei, and Li Zhang
Department of Pharmacy, Changhai Hospital, The Second Military Medical University, Shanghai, China.

Cancer stem cell (CSC) theory reveals a new insight into the understanding of tumorigenesis and metastasis. Recently, DNA methylation is suggested to be a potential epigenetic mechanism for maintenance of CSCs. What's more, studies have shown that DNA methyltransferase (DNMT) is essential for CSCs and deletion of DNMT can reduce tumorigenesis by limiting CSC pool. Therefore, targeting the epigenetic modifiers especially DNA methylation offers an optional strategy for treating human cancers. In the present study we found that DNMT inhibitor 5-Aza-2'-deoxycytidine (5-AzaDC) markedly reduced colorectal CSC abundance in vitro and suppressed liver metastatic tumor growth in vivo. And 5-AzaDC inhibited the expression of active β-catenin and down-regulated the Wnt signaling pathway. The Wnt inhibitors were frequently inactivated by promoter methylation in colorectal cancer; however analysis of TCGA data base showed that only the expression of SFRP1 was significantly reduced in tumors compared to normal tissues. In addition, restoring of SFRP1 expression inhibited the stem cell-like potential of colorectal cancer cells. Our results indicated that inhibition of DNMT blocked the self-renewal of colorectal CSCs and SFRP1 was essential for the maintenance of colorectal CSCs.

UI MeSH Term Description Entries
D008297 Male Males
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077209 Decitabine An azacitidine derivative and antineoplastic antimetabolite. It inhibits DNA methyltransferase to re-activate silent genes, limiting METASTASIS and NEOPLASM DRUG RESISTANCE. Decitabine is used in the treatment of MYELODISPLASTIC SYNDROMES, and ACUTE MYELOID LEUKEMIA. 2'-Deoxy-5-azacytidine,5-Aza-2'-deoxycytidine,5-AzadC,5-Azadeoxycytidine,5-Deoxyazacytidine,5AzadC,AzadC Compound,Dacogen,Decitabine Mesylate,NSC 127716,NSC-127716,2' Deoxy 5 azacytidine,5 Aza 2' deoxycytidine,5 Azadeoxycytidine,5 Deoxyazacytidine,Compound, AzadC,Mesylate, Decitabine,NSC127716
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014183 Transplantation, Heterologous Transplantation between animals of different species. Xenotransplantation,Heterograft Transplantation,Heterografting,Heterologous Transplantation,Xenograft Transplantation,Xenografting,Transplantation, Heterograft,Transplantation, Xenograft
D014411 Neoplastic Stem Cells Highly proliferative, self-renewing, and colony-forming stem cells which give rise to NEOPLASMS. Cancer Stem Cells,Colony-Forming Units, Neoplastic,Stem Cells, Neoplastic,Tumor Stem Cells,Neoplastic Colony-Forming Units,Tumor Initiating Cells,Cancer Stem Cell,Cell, Cancer Stem,Cell, Neoplastic Stem,Cell, Tumor Initiating,Cell, Tumor Stem,Cells, Cancer Stem,Cells, Neoplastic Stem,Cells, Tumor Initiating,Cells, Tumor Stem,Colony Forming Units, Neoplastic,Colony-Forming Unit, Neoplastic,Initiating Cell, Tumor,Initiating Cells, Tumor,Neoplastic Colony Forming Units,Neoplastic Colony-Forming Unit,Neoplastic Stem Cell,Stem Cell, Cancer,Stem Cell, Neoplastic,Stem Cell, Tumor,Stem Cells, Cancer,Stem Cells, Tumor,Tumor Initiating Cell,Tumor Stem Cell,Unit, Neoplastic Colony-Forming,Units, Neoplastic Colony-Forming
D015179 Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. Colorectal Cancer,Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Cancer, Colorectal,Cancers, Colorectal,Carcinoma, Colorectal,Carcinomas, Colorectal,Colorectal Cancers,Colorectal Carcinomas,Colorectal Neoplasm,Colorectal Tumor,Neoplasm, Colorectal,Tumor, Colorectal,Tumors, Colorectal
D015254 DNA Modification Methylases Enzymes that are part of the restriction-modification systems. They are responsible for producing a species-characteristic methylation pattern, on either adenine or cytosine residues, in a specific short base sequence in the host cell's own DNA. This methylated sequence will occur many times in the host-cell DNA and remain intact for the lifetime of the cell. Any DNA from another species which gains entry into a living cell and lacks the characteristic methylation pattern will be recognized by the restriction endonucleases of similar specificity and destroyed by cleavage. Most have been studied in bacterial systems, but a few have been found in eukaryotic organisms. DNA Modification Methyltransferases,Modification Methylases,Methylases, DNA Modification,Methylases, Modification,Methyltransferases, DNA Modification,Modification Methylases, DNA,Modification Methyltransferases, DNA

Related Publications

Shanxin Li, and Zhipeng Han, and Naping Zhao, and Bing Zhu, and Qianwen Zhang, and Xue Yang, and Dandan Sheng, and Jing Hou, and Shiwei Guo, and Lixin Wei, and Li Zhang
May 2022, Pharmacological research,
Shanxin Li, and Zhipeng Han, and Naping Zhao, and Bing Zhu, and Qianwen Zhang, and Xue Yang, and Dandan Sheng, and Jing Hou, and Shiwei Guo, and Lixin Wei, and Li Zhang
September 2018, Life sciences,
Shanxin Li, and Zhipeng Han, and Naping Zhao, and Bing Zhu, and Qianwen Zhang, and Xue Yang, and Dandan Sheng, and Jing Hou, and Shiwei Guo, and Lixin Wei, and Li Zhang
December 2020, Biomedicines,
Shanxin Li, and Zhipeng Han, and Naping Zhao, and Bing Zhu, and Qianwen Zhang, and Xue Yang, and Dandan Sheng, and Jing Hou, and Shiwei Guo, and Lixin Wei, and Li Zhang
October 2017, Cell communication and signaling : CCS,
Shanxin Li, and Zhipeng Han, and Naping Zhao, and Bing Zhu, and Qianwen Zhang, and Xue Yang, and Dandan Sheng, and Jing Hou, and Shiwei Guo, and Lixin Wei, and Li Zhang
March 2023, Journal of agricultural and food chemistry,
Shanxin Li, and Zhipeng Han, and Naping Zhao, and Bing Zhu, and Qianwen Zhang, and Xue Yang, and Dandan Sheng, and Jing Hou, and Shiwei Guo, and Lixin Wei, and Li Zhang
February 2018, Journal of cellular and molecular medicine,
Shanxin Li, and Zhipeng Han, and Naping Zhao, and Bing Zhu, and Qianwen Zhang, and Xue Yang, and Dandan Sheng, and Jing Hou, and Shiwei Guo, and Lixin Wei, and Li Zhang
August 2021, Oncology reports,
Shanxin Li, and Zhipeng Han, and Naping Zhao, and Bing Zhu, and Qianwen Zhang, and Xue Yang, and Dandan Sheng, and Jing Hou, and Shiwei Guo, and Lixin Wei, and Li Zhang
September 2016, Experimental cell research,
Shanxin Li, and Zhipeng Han, and Naping Zhao, and Bing Zhu, and Qianwen Zhang, and Xue Yang, and Dandan Sheng, and Jing Hou, and Shiwei Guo, and Lixin Wei, and Li Zhang
January 2021, Open life sciences,
Shanxin Li, and Zhipeng Han, and Naping Zhao, and Bing Zhu, and Qianwen Zhang, and Xue Yang, and Dandan Sheng, and Jing Hou, and Shiwei Guo, and Lixin Wei, and Li Zhang
October 2019, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
Copied contents to your clipboard!